The use of procalcitonin determinations in evaluation of systemic lupus erythematosus

Journal of Clinical Rheumatology

Volumn 14, Issue 3, 2008, Pages 138-142

  Quintana, Gerardo ^a   Medina, Yimy F ^a,b   Rojas, Cilia ^a   Fernandez, Andrés ^a   Restrepo, José Félix ^a   Rondon, Federico ^a   Iglesias, Antonio ^a  

^a UNIVERSIDAD NACIONAL DE COLOMBIA   (Colombia)

^b NONE   (Colombia)

Author keywords

Infection; Procalcitonin; Systemic lupus erythematosus

Indexed keywords

AZATHIOPRINE; C REACTIVE PROTEIN; CHLOROQUINE; CORTICOSTEROID; CYCLOPHOSPHAMIDE; HYDROXYCHLOROQUINE; METHYLPREDNISOLONE; PREDNISOLONE; PROCALCITONIN; CALCITONIN; PROTEIN PRECURSOR;

ACUTE KIDNEY FAILURE; ADULT; ARTICLE; BACTERIAL INFECTION; BLOOD CULTURE; CALCITONIN BLOOD LEVEL; CASE CONTROL STUDY; CLINICAL FEATURE; CONFIDENCE INTERVAL; CONTROLLED STUDY; DIALYSIS; DISEASE ACTIVITY; DISEASE ASSOCIATION; DRUG DOSE INCREASE; DRUG MEGADOSE; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; FISHER EXACT TEST; GLOMERULONEPHRITIS; HORMONE BLOOD LEVEL; HUMAN; IMMUNOASSAY; LABORATORY DIAGNOSIS; LOBAR PNEUMONIA; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; MYCOSIS; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; SCORING SYSTEM; SENSITIVITY ANALYSIS; STATISTICAL SIGNIFICANCE; SYMPTOM; SYSTEMIC LUPUS ERYTHEMATOSUS; URINALYSIS; URINARY TRACT INFECTION; URINE CULTURE; BLOOD; HOSPITALIZATION; METABOLISM;

ADULT; BACTERIAL INFECTIONS; C-REACTIVE PROTEIN; CALCITONIN; CASE-CONTROL STUDIES; FEMALE; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MYCOSES; PROSPECTIVE STUDIES; PROTEIN PRECURSORS; SEVERITY OF ILLNESS INDEX;

EID: 48249152664     PISSN: 10761608     EISSN: None     Source Type: Journal    
DOI: 10.1097/RHU.0b013e3181772cca     Document Type: Article

References (31)

1. Birnbaum RS, Mahoney WC, Burns DM, et al. Identification of procalcitonin in a rat medullary thyroid carcinoma cell line. J Biol Chem. 1984;259:2870-2874.
2. Becker K, Muller B, Nylen E. Calcitonin gene family of peptides. In: Becker K, ed. Principles and Practice of Endocrinology and Metabolism. 3rd ed. Philadelphia: Lippincott; 2001:520-534.
3. Russwurm S, Stonans I, Stonane E, et al. Procalcitonin and CGRP-1 mRNA expression in various human tissues. Shock. 2001;16:109-112.
4. Russwurm S, Stonans I, Stonane E, et al. Various human tissues express procalcitonin and CGRP-I mRNA. J Anaesth Intensivbehand. 2001;2:55-58.
5. Muller B, White JC, Nylen ES, et al. Ubiquitous expression of the calcitonin-I gene in multiple tissues in response to sepsis. J Clin Endocrinol Metab. 2001;86:396-404.
6. Oberhoffer M, Stonans I, Russwurm S, et al. Procalcitonin expression in human peripheral blood mononuclear cells and its modulation by lipopolysaccharides and sepsis related cytokines in vitro. J Lab Clin Med. 1999;134:49-55.
7. Oberhoffer M, Vogelsang H, Jager E, et al. Katacalcin and calcitonin immunoreactivity in different types of leukocytes indicates intracellular procalcitonin content. Cytokines. 1998;1:1.
8. Nijsten MW, Olinga P, The TH, et al. Procalcitonin behaves as a fast responding acute phase protein in vivo and in vitro. Crit Care Med. 2000;28:458-461.
9. Gabay C, Kushner I. Acute-phase proteins and other systemic responses to inflammation [erratum in N Engl J Med. 1999;340:1376]. N Engl J Med. 1999;340:448-454.
10. Reinhart K, Karzai W, Meisner M. Procalcitonin as a marker of the systemic inflammatory response to infection. Intensive Care Med. 2000; 26:1193-1200.
11. Meisner M. Pathobiochemistry and clinical use of procalcitonin. Clinica Chimica Acta. 2002;323:17-29.
12. Name O, Fernández A, Luaces C. Procalcitonina: una nueva herramienta diagnóstica en la infección bacteriana. Med Clin (Barc). 2002;119:70-74.
13. Gendrel D, Raymond J, Coste J, et al. Comparison of procalcitonin with C-reactive protein, interleukin 6 and interferon-alpha for differentiation of bacterial vs. viral infections. Pediatr Infect Dis J. 1999;18:875-881.
14. Eberhard OK, Haubitz M, Brunkhorst FM, et al. Usefulness of procalcitonin for differentiation between activity of systemic autoimmune disease (systemic lupus erythematosus/systemic antineutrophil cytoplas- mic antibody-associated vasculitis) and invasive bacterial infection. Arthritis Rheum. 1997;40:1250-1256.
15. Schwenger V, Sis J, Breitbart A, Andrassy K. CRP levels in autoimmune disease can be specified by measurement of procalcitonin. Infection. 1998;26:274-276.
16. Meisner M, Reinhart K. Is procalcitonin really a marker of sepsis? Int J Intensive Care. 2001;8:15-25.
17. Chiesa C, Panero A, Rossi N, et al. Reliability of procalcitonin concentrations for the diagnosis of sepsis in critically ill neonates. Clin Infect Dis. 1998;26:664-672.
18. Meisner M. PCT (Procalcitonin) - ein neuer, innovativer Infektionsparameter. Biochemische und klinische Aspekte. New York: Thieme Stuttgart; 2000. ISBN: 3-13-105503-0.
19. Moosig F, Csernok E, Reinhold-Keller E, et al. Elevated procalcitonin levels in active Wegener's granulomatosis. J Rheumatol. 1998;25:1531- 1533.
20. Delèvaux I, André M, Colombier M, et al. Can procalcitonin measurement help in differentiating between bacterial infection and other kinds of inflammatory processes? Ann Rheum Dis. 2003;62:337-340.
21. Okadaa Y, Minakamib H, Tomomasaa T, et al. Serum procalcitonin concentration in patients with Kawasaki disease. J Infection. 2004;48: 199-205.
22. Adam B, Calikoglu E. Serum interleukin-6, procalcitonin and C-reactive protein levels in subjects with active Behçet's disease. J Eur Acad Dermatol Venerol. 2004;18:318-320.
23. Moosig F, Reinhold-Keller E, Csernok E, et al. Limitations on the usefulness of procalcitonin as a marker of infection in patients with systemic autoimmune disease: comment on the article by Eberhard et al. Arthritis Rheum. 1998;41:566-567.
24. Espinosa-Morales R, Escalante A. Use of procalcitonin as a diagnostic test: comment on the article by Eberhard et al. Arthritis Rheum. 1998; 41:567-568.
25. Eberhard OK, Haubitz M, Brunkhorst R. Use of procalcitonin as a diagnostic test: comment on the article by Eberhard et al. Arthritis Rheum. 1998;41:568.
26. Shin KC, Lee VI, Kang SW, et al. Serum procalcitonin measurement for detection of intercurrent infection in febrile patients with SLE. Ann Rheum Dis. 2001;60, 1:988-989.
27. Assicot M, Gendrel D, Carsin H, et al. High serum procalcitonin concentrations in patients with sepsis and infection. Lancet. 1993;341: 515-518.
28. Levy MM, Fink MP, Marshall JC, et al. 2001 SCCM/ESICM/ACCP/ ATS/SIS International Sepsis Definitions Conference. Crit Care Med. 2003;31:1250-1256.
29. Vincent JL. Procalcitonin: the marker of sepsis? Crit Care Med. 2000; 28:1226-1228.
30. de Werra I, Jaccard C, Corradin SB. Cytokines, nitrite/nitrate, soluble tumor necrosis factor receptor, and procalcitonin concentrations: comparisons in patients with septic shock, cardiogenic shock, and bacterial pneumonia. Crit Care Med. 1997;25:607-613.
31. Monneret G, Pachot A, Laroche B, et al. Procalcitonin and calcitonin gene-related peptide decrease LPS-induced TNF production by human circulating blood cells. Cytokine. 1999;12:762-764.